These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening. Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222 [TBL] [Abstract][Full Text] [Related]
28. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders. Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721 [TBL] [Abstract][Full Text] [Related]
29. Epilepsy in patients with GRIN2A alterations: Genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs. von Stülpnagel C; Ensslen M; Møller RS; Pal DK; Masnada S; Veggiotti P; Piazza E; Dreesmann M; Hartlieb T; Herberhold T; Hughes E; Koch M; Kutzer C; Hoertnagel K; Nitanda J; Pohl M; Rostásy K; Haack TB; Stöhr K; Kluger G; Borggraefe I Eur J Paediatr Neurol; 2017 May; 21(3):530-541. PubMed ID: 28109652 [TBL] [Abstract][Full Text] [Related]
30. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia. Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669 [TBL] [Abstract][Full Text] [Related]
31. N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants. Charron JG; Hernandez A; Bilinovich SM; Vogt DL; Bedinger LA; Seaver LH; Williams M; Devries S; Campbell DB; Bupp CP; Prokop JW Am J Med Genet A; 2022 Feb; 188(2):556-568. PubMed ID: 34726335 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy. Hausman-Kedem M; Menascu S; Greenstein Y; Fattal-Valevski A Epilepsy Res; 2020 Jul; 163():106325. PubMed ID: 32289570 [TBL] [Abstract][Full Text] [Related]
33. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment. Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434 [TBL] [Abstract][Full Text] [Related]
34. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors. Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H J Neurochem; 2023 Aug; ():. PubMed ID: 37649269 [TBL] [Abstract][Full Text] [Related]
35. A retrospective analysis of memantine use in a pediatric neurology clinic. Bouhadoun S; Poulin C; Berrahmoune S; Myers KA Brain Dev; 2021 Nov; 43(10):997-1003. PubMed ID: 34074563 [TBL] [Abstract][Full Text] [Related]
36. Loss of Grin2a causes a transient delay in the electrophysiological maturation of hippocampal parvalbumin interneurons. Camp CR; Vlachos A; Klöckner C; Krey I; Banke TG; Shariatzadeh N; Ruggiero SM; Galer P; Park KL; Caccavano A; Kimmel S; Yuan X; Yuan H; Helbig I; Benke TA; Lemke JR; Pelkey KA; McBain CJ; Traynelis SF Commun Biol; 2023 Sep; 6(1):952. PubMed ID: 37723282 [TBL] [Abstract][Full Text] [Related]
37. Functional Evaluation of a De Novo Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851 [TBL] [Abstract][Full Text] [Related]
38. Compound-heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathy. Strehlow V; Rieubland C; Gallati S; Kim S; Myers SJ; Peterson V; Ramsey AJ; Teuscher DD; Traynelis SF; Lemke JR Epilepsia; 2022 Oct; 63(10):e132-e137. PubMed ID: 35983985 [TBL] [Abstract][Full Text] [Related]
39. Conserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes. Brünger T; Pérez-Palma E; Montanucci L; Nothnagel M; Møller RS; Schorge S; Zuberi S; Symonds J; Lemke JR; Brunklaus A; Traynelis SF; May P; Lal D Brain; 2023 Mar; 146(3):923-934. PubMed ID: 36036558 [TBL] [Abstract][Full Text] [Related]
40. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains. Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]